MX355354B - Derivados aminopirimidinicos 4,6-disustituidos novedosos. - Google Patents

Derivados aminopirimidinicos 4,6-disustituidos novedosos.

Info

Publication number
MX355354B
MX355354B MX2015002270A MX2015002270A MX355354B MX 355354 B MX355354 B MX 355354B MX 2015002270 A MX2015002270 A MX 2015002270A MX 2015002270 A MX2015002270 A MX 2015002270A MX 355354 B MX355354 B MX 355354B
Authority
MX
Mexico
Prior art keywords
novel
aminopyrimidine derivatives
disubstituted aminopyrimidine
disubstituted
derivatives
Prior art date
Application number
MX2015002270A
Other languages
English (en)
Other versions
MX2015002270A (es
Inventor
Varga Zoltán
Lori Franco
Kéri György
Chafouleas James
De Forni Davide
Solinas Antonio
Greff Zoltán (Fallecido) Quién Antes De Su Deceso Cedió Sus Respectivos Dereschos De Invención A La
Örfi László
Original Assignee
Virostatics Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virostatics Srl filed Critical Virostatics Srl
Publication of MX2015002270A publication Critical patent/MX2015002270A/es
Publication of MX355354B publication Critical patent/MX355354B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Ciertos derivados aminopirimidínicos 4, 6-disustituidos con sustituyentes tanto aromáticos como halogénicos.
MX2015002270A 2012-08-23 2013-08-23 Derivados aminopirimidinicos 4,6-disustituidos novedosos. MX355354B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261692641P 2012-08-23 2012-08-23
PCT/US2013/056347 WO2014031937A1 (en) 2012-08-23 2013-08-23 Novel 4,6-disubstituted aminopyrimidine derivatives

Publications (2)

Publication Number Publication Date
MX2015002270A MX2015002270A (es) 2015-08-14
MX355354B true MX355354B (es) 2018-04-17

Family

ID=50148518

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015002270A MX355354B (es) 2012-08-23 2013-08-23 Derivados aminopirimidinicos 4,6-disustituidos novedosos.

Country Status (26)

Country Link
US (2) US9617225B2 (es)
EP (1) EP2887943B1 (es)
JP (2) JP6639231B2 (es)
KR (1) KR102209229B1 (es)
CN (1) CN104822380B (es)
AU (1) AU2013305634B2 (es)
BR (1) BR112015003655A2 (es)
CA (1) CA2882733C (es)
DK (1) DK2887943T3 (es)
EA (1) EA029278B1 (es)
ES (1) ES2661717T3 (es)
HK (1) HK1213482A1 (es)
HR (1) HRP20180285T1 (es)
HU (1) HUE036288T2 (es)
IL (2) IL237143A (es)
LT (1) LT2887943T (es)
MX (1) MX355354B (es)
NO (1) NO2970314T3 (es)
NZ (1) NZ705313A (es)
PL (1) PL2887943T3 (es)
SG (2) SG11201501041VA (es)
SI (1) SI2887943T1 (es)
TR (1) TR201802913T4 (es)
UA (1) UA117814C2 (es)
WO (1) WO2014031937A1 (es)
ZA (1) ZA201501600B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ705313A (en) * 2012-08-23 2018-03-23 Virostatics Srl Novel 4,6-disubstituted aminopyrimidine derivatives
CN104151178B (zh) * 2014-08-06 2016-08-17 江苏鼎龙科技有限公司 2-氨基-4-(β-羟乙基氨基)苯甲醚及其硫酸盐的制备方法
WO2016059011A1 (en) 2014-10-16 2016-04-21 Bayer Pharma Aktiengesellschaft Fluorinated benzofuranyl-pyrimidine derivatives containing a sulfone group
US10087191B2 (en) 2015-06-16 2018-10-02 Jiangsu Hengrui Medicine Co., Ltd. Piperidine derivative and preparation method and pharmaceutical use thereof
CN108290903B (zh) 2015-09-29 2021-09-03 拜耳医药股份有限公司 新的大环磺酰二亚胺化合物
EP3359544B1 (en) 2015-10-08 2020-08-12 Bayer Pharma Aktiengesellschaft Novel modified macrocyclic compounds
WO2017060322A2 (en) 2015-10-10 2017-04-13 Bayer Pharma Aktiengesellschaft Ptefb-inhibitor-adc
EP3190103A1 (en) * 2016-01-08 2017-07-12 Rijksuniversiteit Groningen Inhibitors of the pd-1/pd-l1 protein/protein interaction
ES2900199T3 (es) 2017-03-28 2022-03-16 Bayer Ag Novedosos compuestos macrocíclicos inhibidores de PTEFB
CA3057891A1 (en) 2017-03-28 2018-10-04 Bayer Aktiengesellschaft Novel ptefb inhibiting macrocyclic compounds
CN109761909B (zh) * 2019-01-25 2022-08-26 中国药科大学 N-(4-(嘧啶-4-氨基)苯基)磺酰胺类抑制剂或其可药用的盐、其制备方法及用途
IT201900004737A1 (it) 2019-03-29 2020-09-29 Virostatics Srl Composti aventi attività enzimatica anti-CDK4/6 e anti-CDK9 per l’inibizione della proliferazione del cancro e relativi metodi di screening per la loro identificazione.
CN111269215B (zh) * 2020-04-01 2021-10-26 中科利健制药(广州)有限公司 含氮杂环有机化合物及其制备方法和应用
CA3188521A1 (en) * 2020-08-07 2022-02-10 Zuozhong PENG Cdk9 inhibitor and use thereof
WO2022195522A1 (en) * 2021-03-17 2022-09-22 Ildong Pharmaceutical Co., Ltd. Inhibitors of ano6 and their uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6114365A (en) 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US6757135B2 (en) 2000-07-28 2004-06-29 Seagate Technology Llc Leading edge bond pads
MXPA03001226A (es) * 2000-08-08 2004-09-10 Johnson & Johnson Derivados de 4-pirimidinamina, composiciones farmaceuticas y metodos relacionados.
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
ATE527250T1 (de) * 2002-11-21 2011-10-15 Novartis Ag 2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
BRPI0412347A (pt) * 2003-07-30 2006-09-05 Cyclacel Ltd 2-aminofenil-4-fenilpiridinas como inibidores de quinase
US8084457B2 (en) * 2003-09-15 2011-12-27 Lead Discovery Center Gmbh Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
JP2008542219A (ja) * 2005-05-25 2008-11-27 インゲニウム ファーマシューティカルズ ジーエムビーエイチ 疼痛処置法
US8507498B2 (en) * 2007-04-24 2013-08-13 Ingenium Pharmaceuticals Gmbh 4, 6-disubstituted aminopyrimidine derivatives as inhibitors of protein kinases
HU0900798D0 (en) 2009-12-21 2010-03-01 Vichem Chemie Kutato Kft 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
WO2013175415A1 (en) * 2012-05-23 2013-11-28 Piramal Enterprises Limited Substituted pyrimidine compounds and uses thereof
NZ705313A (en) * 2012-08-23 2018-03-23 Virostatics Srl Novel 4,6-disubstituted aminopyrimidine derivatives

Also Published As

Publication number Publication date
CN104822380A (zh) 2015-08-05
NO2970314T3 (es) 2018-05-12
HRP20180285T1 (hr) 2018-04-20
EA201590417A1 (ru) 2015-07-30
US20140057911A1 (en) 2014-02-27
US9617225B2 (en) 2017-04-11
DK2887943T3 (en) 2018-03-12
HK1213482A1 (zh) 2016-07-08
BR112015003655A2 (pt) 2017-07-04
UA117814C2 (uk) 2018-10-10
EP2887943A1 (en) 2015-07-01
EP2887943B1 (en) 2017-12-06
AU2013305634A1 (en) 2015-03-12
KR20150064730A (ko) 2015-06-11
WO2014031937A1 (en) 2014-02-27
IL237143A0 (en) 2015-04-30
CN104822380B (zh) 2019-01-01
SG10201701438QA (en) 2017-03-30
NZ705313A (en) 2018-03-23
PL2887943T3 (pl) 2018-05-30
IL253061A0 (en) 2017-08-31
JP6781736B2 (ja) 2020-11-04
US10294218B2 (en) 2019-05-21
TR201802913T4 (tr) 2018-03-21
JP6639231B2 (ja) 2020-02-05
LT2887943T (lt) 2018-05-25
HUE036288T2 (hu) 2018-06-28
US20170204084A1 (en) 2017-07-20
CA2882733A1 (en) 2014-02-27
SI2887943T1 (en) 2018-04-30
CA2882733C (en) 2021-07-27
EA029278B1 (ru) 2018-03-30
IL253061B (en) 2018-03-29
ZA201501600B (en) 2020-12-23
KR102209229B1 (ko) 2021-01-29
EP2887943A4 (en) 2016-01-13
JP2015526479A (ja) 2015-09-10
IL237143A (en) 2017-07-31
SG11201501041VA (en) 2015-03-30
JP2018197233A (ja) 2018-12-13
AU2013305634B2 (en) 2018-03-22
ES2661717T3 (es) 2018-04-03
MX2015002270A (es) 2015-08-14

Similar Documents

Publication Publication Date Title
UA117814C2 (uk) 4,6-дизаміщені амінопіримідинові похідні
PH12015501393A1 (en) Pesticidal compositions and processes related thereto
PH12014502398A1 (en) Pesticidal compositions and processes related thereto
PH12014502169A1 (en) N-cyclylamides as nematicides
UY4277S (es) Camara
MX2015011837A (es) Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada.
PH12015502146A1 (en) 4-amino-6-(4-substituted-phenyl)-picolinates and 6-amino-2-(4-substituted-phenyl)-pyrimidine-4-carboxylates and their use as herbicides
PH12017501071A1 (en) Dihydropyrimidin-2-one compounds and medical use thereof
MX2016004393A (es) Derivados de carboxamida como compuestos pesticidas.
UY34677A (es) Imidazopiridazinas sustituidas
UA78285U (en) N- methylmorpholinium 4-(4-ethoxyphenyl)-2-oxo-5-cyano-1,2,3,4-tetrahydropyridine-6-thiolate
UA88023U (ru) Соединение 1,3-бис-(2-гидроксиэтил)-урацил с потенциальными физиологическими свойствами
UA91886U (uk) 1-трет-бутокси-3-(2,2,6,6-тетраметил-4-гідроксипіперидино)-2-пропанол
UA74648U (uk) Похідні 1,2,4-триазолів, що проявляють протимікробну активність
UA79050U (en) N-methylmorpholinium 4-(2,5-dimethoxyphenyl)-2-oxo-5-cyano-1,2,3,4-tetrahydropyridine-6-thiolate
MX2015008110A (es) Cicloclavina y derivados de esta para controlar plagas de invertebrados.
UA50962U (ru) Производные хиназолона, обладающие антиоксидантной активностью
UA56041U (ru) 1,3-диметил-7-n-метилбензил-8-гидразиноксантин, который проявляет диуретическое действие
UA86446U (ru) Соединение 1,1'-(2"-бром-2"-хлорэтенил)-бис-(урацил) с потенциальными физиологическими свойствами
UA80618U (en) Use of n-steroylethanolamine as radiomodifier
UA85088U (en) 4-(1-naphthyl)-2-oxo-5-cyano-1,2,3,4-tetrahydropyridine-6-thiolate n- methylmorpholinium
UA80877U (en) 2-hydroxyethyl-1,3,4-trimethylcyclohex-3-ene-1-carboxylate
UA76716U (uk) 5,7-ДИМЕТИЛ-2-ОКСО-6-ФЕНІЛАЗО-ТІАЗОЛО[4,5-b]ПІРИДИН-3-ІЛГІДРАЗОНИ АЦЕТАТНОЇ КИСЛОТИ, ЩО ПРОЯВЛЯЮТЬ АНТИЕКСУДАТИВНУ ДІЮ
UA86449U (ru) Соединение 1,1'-(2"-бром-2"-хлорэтенил)-бис-(5-нитроурацил) с потенциальными физиологическими свойствами
AU354730S (en) Roulette 73

Legal Events

Date Code Title Description
FG Grant or registration